{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:12:30Z","timestamp":1794003150653,"version":"4.8.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0179-4","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T15:04:44Z","timestamp":1416927884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":296,"title":["Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management"],"prefix":"10.1186","volume":"9","author":[{"given":"Shuke","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"key":"179_CR1","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","volume":"266","author":"JJ Cali","year":"1991","unstructured":"Cali JJ, Hsieh CL, Francke U, Russell DW: Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991, 266: 7779-7783.","journal-title":"J Biol Chem"},{"key":"179_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","volume":"27","author":"GN Gallus","year":"2006","unstructured":"Gallus GN, Dotti MT, Federico A: Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci. 2006, 27: 143-149.","journal-title":"Neurol Sci"},{"key":"179_CR3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2010.02.140","volume":"396","author":"I Bjorkhem","year":"2010","unstructured":"Bjorkhem I, Hansson M: Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem Biophys Res Commun. 2010, 396: 46-49.","journal-title":"Biochem Biophys Res Commun"},{"key":"179_CR4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.62.9.1459","volume":"62","author":"MT Lorincz","year":"2005","unstructured":"Lorincz MT, Rainier S, Thomas D, Fink JK: Cerebrotendinous xanthomatosis - Possible higher prevalence than previously recognized. Arch Neurol. 2005, 62: 1459-1463.","journal-title":"Arch Neurol"},{"key":"179_CR5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","volume":"18","author":"B Pilo-de-la-Fuente","year":"2011","unstructured":"Pilo-de-la-Fuente B, Jimenez-Escrig A, Lorenzo JR, Pardo J, Arias M, Ares-Luque A, Duarte J, Muniz-Perez S, Sobrido MJ: Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol. 2011, 18: 1203-1211.","journal-title":"Eur J Neurol"},{"key":"179_CR6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI107688","volume":"53","author":"T Setoguchi","year":"1974","unstructured":"Setoguchi T, Salen G, Tint GS, Mosbach EH: A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. J Clin Invest. 1974, 53: 1393-1401.","journal-title":"J Clin Invest"},{"key":"179_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003, 72: 137-174.","journal-title":"Annu Rev Biochem"},{"key":"179_CR8","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","volume":"279","author":"G Lorbek","year":"2012","unstructured":"Lorbek G, Lewinska M, Rozman D: Cytochrome P450s in the synthesis of cholesterol and bile acids - from mouse models to human diseases. Febs J. 2012, 279: 1516-1533.","journal-title":"Febs J"},{"key":"179_CR9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","volume":"40","author":"WC Duane","year":"1999","unstructured":"Duane WC, Javitt NB: 27-hydroxycholesterol: production rates in normal human subjects. J Lipid Res. 1999, 40: 1194-1199.","journal-title":"J Lipid Res"},{"key":"179_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.berh.2011.10.016","volume":"25","author":"G Chales","year":"2011","unstructured":"Chales G, Coiffier G, Guggenbuhl P: Miscellaneous non-inflammatory musculoskeletal conditions. Rare thesaurismosis and xanthomatosis. Best Pract Res Clin Rheumatol. 2011, 25: 683-701.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"179_CR11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI111719","volume":"75","author":"S Skrede","year":"1985","unstructured":"Skrede S, Bjorkhem I, Buchmann MS, Hopen G, Fausa O: A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J Clin Invest. 1985, 75: 448-455.","journal-title":"J Clin Invest"},{"key":"179_CR12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1194\/jlr.M700027-JLR200","volume":"48","author":"U Panzenboeck","year":"2007","unstructured":"Panzenboeck U, Andersson U, Hansson M, Sattler W, Meaney S, Bjorkhem I: On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. J Lipid Res. 2007, 48: 1167-1174.","journal-title":"J Lipid Res"},{"key":"179_CR13","first-page":"6","volume":"7","author":"Z Keren","year":"2009","unstructured":"Keren Z, Falik-Zaccai TC: Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease. Pediatr Endocrinol Rev. 2009, 7: 6-11.","journal-title":"Pediatr Endocrinol Rev"},{"key":"179_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004310050818","volume":"157","author":"AFJ van Heijst","year":"1998","unstructured":"van Heijst AFJ, Verrips A, Wevers RA, Cruysberg JRM, Renier WO, Tolboom JJM: Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr. 1998, 157: 313-316.","journal-title":"Eur J Pediatr"},{"key":"179_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9394(14)76874-6","volume":"112","author":"JR Cruysberg","year":"1991","unstructured":"Cruysberg JR, Wevers RA, Tolboom JJ: Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol. 1991, 112: 606-607.","journal-title":"Am J Ophthalmol"},{"key":"179_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.a.30797","volume":"139A","author":"L Guyant-Marechal","year":"2005","unstructured":"Guyant-Marechal L, Verrips A, Girard C, Wevers RA, Zijlstra F, Sistermans E, Vera P, Campion D, Hannequin D: Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet A. 2005, 139A: 114-117.","journal-title":"Am J Med Genet A"},{"key":"179_CR17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-007-0661-4","volume":"30","author":"F Sedel","year":"2007","unstructured":"Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D: Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007, 30: 631-641.","journal-title":"J Inherit Metab Dis"},{"key":"179_CR18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1586\/14737175.8.11.1731","volume":"8","author":"K Kalidas","year":"2008","unstructured":"Kalidas K, Behrouz R: Inherited metabolic disorders and cerebral infarction. Expert Rev Neurother. 2008, 8: 1731-1741.","journal-title":"Expert Rev Neurother"},{"key":"179_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2012.04.121","volume":"24","author":"JL Pedroso","year":"2012","unstructured":"Pedroso JL, Pinto WB, Souza PV, Santos LT, Abud IC, Avelino MA, Barsottini OG: Early-onset epilepsy as the main neurological manifestation of cerebrotendinous xanthomatosis. Epilepsy Behav. 2012, 24: 380-381.","journal-title":"Epilepsy Behav"},{"key":"179_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(00)00441-X","volume":"182","author":"T Ohno","year":"2001","unstructured":"Ohno T, Kobayashi S, Hayashi M, Sakurai M, Kanazawa I: Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients. J Neurol Sci. 2001, 182: 95-97.","journal-title":"J Neurol Sci"},{"key":"179_CR21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/08830738030180091001","volume":"18","author":"A Federico","year":"2003","unstructured":"Federico A, Dotti MT: Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol. 2003, 18: 633-638.","journal-title":"J Child Neurol"},{"key":"179_CR22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.59.4.527","volume":"59","author":"MH Moghadasian","year":"2002","unstructured":"Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH: Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol. 2002, 59: 527-529.","journal-title":"Arch Neurol"},{"key":"179_CR23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","volume":"311","author":"VM Berginer","year":"1984","unstructured":"Berginer VM, Salen G, Shefer S: Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984, 311: 1649-1652.","journal-title":"N Engl J Med"},{"issue":"578","key":"179_CR24","first-page":"e571","volume":"34","author":"Q Chen","year":"2012","unstructured":"Chen Q, Liu W, Jiang B, Yu R, Li X, Li H: Fluoxetine-responsive depression in a Chinese cerebrotendinous xanthomatosis. Gen Hosp Psychiatry. 2012, 34 (578): e571-e574.","journal-title":"Gen Hosp Psychiatry"},{"key":"179_CR25","first-page":"334","volume":"25","author":"Y Lee","year":"2002","unstructured":"Lee Y, Lin PY, Chiu NM, Chang WN, Wen JK: Cerebrotendinous xanthomatosis with psychiatric disorders: report of three siblings and literature review. Chang Gung Med J. 2002, 25: 334-340.","journal-title":"Chang Gung Med J"},{"key":"179_CR26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/mds.25206","volume":"27","author":"J Lagarde","year":"2012","unstructured":"Lagarde J, Roze E, Apartis E, Pothalil D, Sedel F, Couvert P, Vidailhet M, Degos B: Myoclonus and dystonia in cerebrotendinous xanthomatosis. Mov Disord. 2012, 27: 1805-1810.","journal-title":"Mov Disord"},{"key":"179_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0002-9394(14)72206-8","volume":"120","author":"JR Cruysberg","year":"1995","unstructured":"Cruysberg JR, Wevers RA, van Engelen BG, Pinckers A, van Spreeken A, Tolboom JJ: Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol. 1995, 120: 597-604.","journal-title":"Am J Ophthalmol"},{"key":"179_CR28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s004150050274","volume":"245","author":"MT Dotti","year":"1998","unstructured":"Dotti MT, Mondillo S, Plewnia K, Agricola E, Federico A: Cerebrotendinous xanthomatosis: evidence of lipomatous hypertrophy of the atrial septum. J Neurol. 1998, 245: 723-726.","journal-title":"J Neurol"},{"key":"179_CR29","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1073\/pnas.91.18.8592","volume":"91","author":"I Bjorkhem","year":"1994","unstructured":"Bjorkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu RJ, Duan C, Lund E: Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci U S A. 1994, 91: 8592-8596.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"179_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2009.09.015","volume":"209","author":"O Weingartner","year":"2010","unstructured":"Weingartner O, Laufs U, Bohm M, Lutjohann D: An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis. 2010, 209: 39-41.","journal-title":"Atherosclerosis"},{"key":"179_CR31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0026-0495(93)90205-3","volume":"42","author":"M Kuriyama","year":"1993","unstructured":"Kuriyama M, Fujiyama J, Kubota R, Nakagawa M, Osame M: Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism. 1993, 42: 1497-1498.","journal-title":"Metabolism"},{"key":"179_CR32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00223-012-9677-3","volume":"92","author":"G Martini","year":"2013","unstructured":"Martini G, Mignarri A, Ruvio M, Valenti R, Franci B, Del Puppo M, Federico A, Nuti R, Dotti MT: Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int. 2013, 92: 282-286.","journal-title":"Calcif Tissue Int"},{"key":"179_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-510X(93)90068-A","volume":"115","author":"A Federico","year":"1993","unstructured":"Federico A, Dotti MT, Lore F, Nuti R: Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci. 1993, 115: 67-70.","journal-title":"J Neurol Sci"},{"key":"179_CR34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2169\/internalmedicine.37.922","volume":"37","author":"M Kawabata","year":"1998","unstructured":"Kawabata M, Kuriyama M, Mori S, Sakashita I, Osame M: Pulmonary manifestations in cerebrotendinous xanthomatosis. Intern Med. 1998, 37: 922-926.","journal-title":"Intern Med"},{"key":"179_CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1378\/chest.112.1.273","volume":"112","author":"TP Dormans","year":"1997","unstructured":"Dormans TP, Verrips A, Bulten J, Cox N: Pulmonary lymphangioleiomyomatosis and cerebrotendinous xanthomatosis: is there a link?. Chest. 1997, 112: 273-274.","journal-title":"Chest"},{"key":"179_CR36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.57.4.520","volume":"57","author":"A Verrips","year":"2000","unstructured":"Verrips A, van Engelen BG, Wevers RA, van Geel BM, Cruysberg JR, van den Heuvel LP, Keyser A, Gabreels FJ: Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol. 2000, 57: 520-524.","journal-title":"Arch Neurol"},{"key":"179_CR37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1651-2227.1996.tb14189.x","volume":"85","author":"AF van Heijst","year":"1996","unstructured":"van Heijst AF, Wevers RA, Tangerman A, Cruysberg JR, Renier WO, Tolboom JJ: Chronic diarrhea as a dominating symptom in two children with cerebrotendinous xanthomatosis. Acta Paediatr (Oslo, Norway: 1992). 1996, 85: 932-936.","journal-title":"Acta Paediatr (Oslo, Norway: 1992)"},{"key":"179_CR38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","volume":"37","author":"A Mignarri","year":"2014","unstructured":"Mignarri A, Gallus GN, Dotti MT, Federico A: A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014, 37: 421-429.","journal-title":"J Inherit Metab Dis"},{"key":"179_CR39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00415-012-6630-3","volume":"260","author":"F Ginanneschi","year":"2013","unstructured":"Ginanneschi F, Mignarri A, Mondelli M, Gallus GN, Del Puppo M, Giorgi S, Federico A, Rossi A, Dotti MT: Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol. 2013, 260: 268-274.","journal-title":"J Neurol"},{"key":"179_CR40","first-page":"385","volume":"147","author":"M Ben Hamida","year":"1991","unstructured":"Ben Hamida M, Chabbi N, Ben Hamida C, Mhiri C, Kallel R: [Peripheral neuropathy in a sporadic case of cerebrotendinous xanthomatosis]. Neuropathie peripherique dans un cas sporadique de xanthomatose cerebrotendineuse. Rev Neurol. 1991, 147: 385-388.","journal-title":"Rev Neurol"},{"key":"179_CR41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ana.410300517","volume":"30","author":"A Federico","year":"1991","unstructured":"Federico A, Dotti MT, Volpi N: Muscle mitochondrial changes in cerebrotendinous xanthomatosis. Ann Neurol. 1991, 30: 734-735.","journal-title":"Ann Neurol"},{"key":"179_CR42","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.57.9.1743","volume":"57","author":"A Federico","year":"2001","unstructured":"Federico A, Dotti MT: Cerebrotendinous xanthomatosis. Neurology. 2001, 57: 1743-","journal-title":"Neurology"},{"key":"179_CR43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.clinbiochem.2014.04.017","volume":"47","author":"AE DeBarber","year":"2014","unstructured":"DeBarber AE, Luo J, Giugliani R, Souza CFM, Chiang JP-W, Merkens LS, Pappu AS, Steiner RD: A useful multi-analyte blood test for cerebrotendinous xanthomatosis. Clin Biochem. 2014, 47: 860-863.","journal-title":"Clin Biochem"},{"key":"179_CR44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00415-010-5829-4","volume":"258","author":"A Mignarri","year":"2011","unstructured":"Mignarri A, Rossi S, Ballerini M, Gallus GN, Del Puppo M, Galluzzi P, Federico A, Dotti MT: Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis. J Neurol. 2011, 258: 783-790.","journal-title":"J Neurol"},{"key":"179_CR45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/mus.21905","volume":"43","author":"B Pilo","year":"2011","unstructured":"Pilo B, de Blas G, Sobrido MJ, Navarro C, Grandas F, Barrero FJ, Moya MA, Jimenez-Escrig A: Neurophysiological study in cerebrotendinous xanthomatosis. Muscle Nerve. 2011, 43: 531-536.","journal-title":"Muscle Nerve"},{"key":"179_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-11-63","volume":"11","author":"S-F Chen","year":"2011","unstructured":"Chen S-F, Tsai N-W, Chang C-C, Lu C-H, Huang C-R, Chuang Y-C, Chang W-N: Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis. BMC Neurol. 2011, 11: 63-","journal-title":"BMC Neurol"},{"key":"179_CR47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archneur.1992.00530290051011","volume":"49","author":"M Mondelli","year":"1992","unstructured":"Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A: Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. Arch Neurol. 1992, 49: 469-475.","journal-title":"Arch Neurol"},{"key":"179_CR48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s003300050964","volume":"10","author":"F Vanrietvelde","year":"2000","unstructured":"Vanrietvelde F, Lemmerling M, Mespreuve M, Crevits L, De Reuck J, Kunnen M: MRI of the brain in cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease). Eur Radiol. 2000, 10: 576-578.","journal-title":"Eur Radiol"},{"key":"179_CR49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00234-012-1026-8","volume":"54","author":"A Mignarri","year":"2012","unstructured":"Mignarri A, Dotti MT, Del Puppo M, Gallus GN, Giorgio A, Cerase A, Monti L: Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: six-year MRI follow-up. Neuroradiology. 2012, 54: 649-651.","journal-title":"Neuroradiology"},{"key":"179_CR50","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1212\/01.wnl.0000316806.01406.74","volume":"71","author":"BP Mehta","year":"2008","unstructured":"Mehta BP, Shmerling RH: Teaching neuroimage: cerebrotendinous xanthomatosis. Neurology. 2008, 71: e4-","journal-title":"Neurology"},{"key":"179_CR51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/brain\/124.1.121","volume":"124","author":"N De Stefano","year":"2001","unstructured":"De Stefano N, Dotti MT, Mortilla M, Federico A: Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain: J Neurol. 2001, 124: 121-131.","journal-title":"Brain: J Neurol"},{"key":"179_CR52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1148\/radiology.217.3.r00dc03869","volume":"217","author":"F Barkhof","year":"2000","unstructured":"Barkhof F, Verrips A, Wesseling P, van Der Knaap MS, van Engelen BG, Gabreels FJ, Keyser A, Wevers RA, Valk J: Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology. 2000, 217: 869-876.","journal-title":"Radiology"},{"key":"179_CR53","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1212\/01.WNL.0000158671.84150.8F","volume":"64","author":"CS Clemen","year":"2005","unstructured":"Clemen CS, Spottke EA, Lutjohann D, Urbach H, von Bergmann K, Klockgether T, Dodel R: Cerebrotendinous xanthomatosis: a treatable ataxia. Neurology. 2005, 64: 1476-","journal-title":"Neurology"},{"key":"179_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2377-10-59","volume":"10","author":"C-C Chang","year":"2010","unstructured":"Chang C-C, Lui C-C, Wang J-J, Huang S-H, Lu C-H, Chen C, Chen C-F, Tu M-C, Huang C-W, Chang W-N: Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations. BMC Neurol. 2010, 10: 59-","journal-title":"BMC Neurol"},{"key":"179_CR55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/jnnp.2009.203364","volume":"81","author":"S Guerrera","year":"2010","unstructured":"Guerrera S, Stromillo ML, Mignarri A, Battaglini M, Marino S, Di Perri C, Federico A, Dotti MT, De Stefano N: Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry. 2010, 81: 1189-1193.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"179_CR56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn1119","volume":"4","author":"D Le Bihan","year":"2003","unstructured":"Le Bihan D: Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci. 2003, 4: 469-480.","journal-title":"Nat Rev Neurosci"},{"key":"179_CR57","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3174\/ajnr.A1885","volume":"31","author":"EK Embirucu","year":"2010","unstructured":"Embirucu EK, Otaduy MCG, Taneja AK, Leite CC, Kok F, Lucato LT: MR spectroscopy detects lipid peaks in cerebrotendinous xanthomatosis. AJNR Am J Neuroradiol. 2010, 31: 1347-1349.","journal-title":"AJNR Am J Neuroradiol"},{"key":"179_CR58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jnnp.2009.196444","volume":"82","author":"S Seidel","year":"2011","unstructured":"Seidel S, Kasprian G, Prayer D, Krssak M, Sycha T, Auff E: Visualisation of treatment response in a case of cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry. 2011, 82: 703-704.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"179_CR59","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10072-012-1262-z","volume":"34","author":"P Caroppo","year":"2013","unstructured":"Caroppo P, D\u2019Agata F, Mignarri A, Stromillo ML, Dotti MT, Mongini T: Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. Neurol Sci: Offic J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2013, 34: 1693-1696.","journal-title":"Neurol Sci: Offic J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"179_CR60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RLU.0b013e3181feed83","volume":"36","author":"A Selva-O\u2019Callaghan","year":"2011","unstructured":"Selva-O\u2019Callaghan A, Bardes I, Jacas C, Jubany L, Lorenzo-Bosquet C, Cuberas-Borros G, Vilardell-Tarres M: SPECT imaging for brain improvement quantification in a patient with cerebrotendinous xanthomatosis. Clin Nucl Med. 2011, 36: 38-39.","journal-title":"Clin Nucl Med"},{"key":"179_CR61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13760-012-0064-7","volume":"112","author":"K Schotsmans","year":"2012","unstructured":"Schotsmans K, De Cauwer H, Baets J, Ceyssens S, van den Hauwe L, Deconinck T, Helsen G: Cerebrotendinous xanthomatosis presenting with asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging. Acta Neurol Belg. 2012, 112: 287-289.","journal-title":"Acta Neurol Belg"},{"key":"179_CR62","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1097\/RLU.0b013e3182a20d8e","volume":"39","author":"S-F Chen","year":"2014","unstructured":"Chen S-F, Chang C-C, Huang S-H, Lu C-H, Chuang Y-C, Pan T-L, Chang W-N: 99mTc-sestamibi thigh SPECT\/CT imaging for assessment of myopathy in cerebrotendinous xanthomatosis with histopathological and immunohistochemical correlation. Clin Nucl Med. 2014, 39: e202-e207.","journal-title":"Clin Nucl Med"},{"key":"179_CR63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(96)00011-1","volume":"138","author":"K Kuwabara","year":"1996","unstructured":"Kuwabara K, Hitoshi S, Nukina N, Ishii K, Momose T, Kubota S, Seyama Y, Kanazawa I: PET analysis of a case of cerebrotendinous xanthomatosis presenting hemiparkinsonism. J Neurol Sci. 1996, 138: 145-149.","journal-title":"J Neurol Sci"},{"key":"179_CR64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00415-008-0729-6","volume":"255","author":"B Pilo de la Fuente","year":"2008","unstructured":"Pilo de la Fuente B, Ruiz I, Lopez de Munain A, Jimenez-Escrig A: Cerebrotendinous xanthomatosis: neuropathological findings. J Neurol. 2008, 255: 839-842.","journal-title":"J Neurol"},{"key":"179_CR65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00294324","volume":"90","author":"D Soffer","year":"1995","unstructured":"Soffer D, Benharroch D, Berginer V: The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol. 1995, 90: 213-220.","journal-title":"Acta Neuropathol"},{"key":"179_CR66","first-page":"141","volume":"35","author":"H Kato","year":"2003","unstructured":"Kato H, Koyabu S, Aoki S, Tamai T, Sugawa M, Watanabe M, Shiraishi T: An autopsy case of gallbladder cancer developing in a Japanese man with cerebrotendinous xanthomatosis: genetic analysis of the sterol 27-hydroxylase and p53 genes. Pathology. 2003, 35: 141-144.","journal-title":"Pathology"},{"key":"179_CR67","first-page":"433","volume":"17","author":"L Van Bogaert","year":"1962","unstructured":"Van Bogaert L: [The framework of the xanthomatoses and their different types. 2. Secondary xanthomatoses]. Rev Med Liege. 1962, 17: 433-443.","journal-title":"Rev Med Liege"},{"key":"179_CR68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-510X(87)90009-8","volume":"82","author":"V Voiculescu","year":"1987","unstructured":"Voiculescu V, Alexianu M, Popescu-Tismana G, Pastia M, Petrovici A, Dan A: Polyneuropathy with lipid deposits in Schwann cells and axonal degeneration in cerebrotendinous xanthomatosis. J Neurol Sci. 1987, 82: 89-99.","journal-title":"J Neurol Sci"},{"key":"179_CR69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00691803","volume":"45","author":"A Ohnishi","year":"1979","unstructured":"Ohnishi A, Yamashita Y, Goto I, Kuroiwa Y, Murakami S, Ikeda M: De- and remyelination and onion bulb in cerebrotendinous xanthomatosis. Acta Neuropathol. 1979, 45: 43-45.","journal-title":"Acta Neuropathol"},{"key":"179_CR70","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2377-11-130","volume":"11","author":"D Tian","year":"2011","unstructured":"Tian D, Zhang Z-Q: 2 Novel deletions of the sterol 27-hydroxylase gene in a Chinese family with cerebrotendinous xanthomatosis. BMC Neurol. 2011, 11: 130-","journal-title":"BMC Neurol"},{"key":"179_CR71","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archneur.1968.00470360110011","volume":"18","author":"JR Schimschock","year":"1968","unstructured":"Schimschock JR, Alvord EC, Swanson PD: Cerebrotendinous xanthomatosis. Clinical and pathological studies. Arch Neurol. 1968, 18: 688-698.","journal-title":"Arch Neurol"},{"key":"179_CR72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-5-27","volume":"5","author":"H Schneider","year":"2010","unstructured":"Schneider H, Lingesleben A, Vogel H-P, Garuti R, Calandra S: A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. Orphanet J Rare Dis. 2010, 5: 27-","journal-title":"Orphanet J Rare Dis"},{"key":"179_CR73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0960-8966(00)00112-7","volume":"10","author":"A Verrips","year":"2000","unstructured":"Verrips A, van Engelen BG, ter Laak H, Gabreels-Festen A, Janssen A, Zwarts M, Wevers RA, Gabreels FJ: Cerebrotendinous xanthomatosis. Controversies about nerve and muscle: observations in ten patients. Neuromuscul Disord: NMD. 2000, 10: 407-414.","journal-title":"Neuromuscul Disord: NMD"},{"key":"179_CR74","doi-asserted-by":"crossref","first-page":"e35333","DOI":"10.1371\/journal.pone.0035333","volume":"7","author":"FP Diekstra","year":"2012","unstructured":"Diekstra FP, Saris CGJ, van Rheenen W, Franke L, Jansen RC, van Es MA, van Vught PWJ, Blauw HM, Groen EJN, Horvath S, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Robberecht W, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH, Shatunov A, Shaw CE, Leigh PN, Al-Chalabi A, Ophoff RA, van den Berg LH, Veldink JH: Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One. 2012, 7: e35333-","journal-title":"PLoS One"},{"key":"179_CR75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MOL.0b013e328362df13","volume":"24","author":"I Bjorkhem","year":"2013","unstructured":"Bjorkhem I: Cerebrotendinous xanthomatosis. Curr Opin Lipidol. 2013, 24: 283-287.","journal-title":"Curr Opin Lipidol"},{"key":"179_CR76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.5551\/jat.4614","volume":"17","author":"K Tsubakio-Yamamoto","year":"2010","unstructured":"Tsubakio-Yamamoto K, Nishida M, Nakagawa-Toyama Y, Masuda D, Ohama T, Yamashita S: Current therapy for patients with sitosterolemia-effect of ezetimibe on plant sterol metabolism. J Atheroscler Thromb. 2010, 17: 891-900.","journal-title":"J Atheroscler Thromb"},{"key":"179_CR77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-010-9126-2","volume":"33","author":"DM Niu","year":"2010","unstructured":"Niu DM, Chong KW, Hsu JH, Wu TJ, Yu HC, Huang CH, Lo MY, Kwok CF, Kratz LE, Ho LT: Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and children. J Inherit Metab Dis. 2010, 33: 437-443.","journal-title":"J Inherit Metab Dis"},{"key":"179_CR78","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI3963","volume":"102","author":"SB Patel","year":"1998","unstructured":"Patel SB, Salen G, Hidaka H, Kwiterovich PO, Stalenhoef AFH, Miettinen TA, Grundy SM, Lee MH, Rubenstein JS, Polymeropoulos MH, Brownstein MJ: Mapping a gene involved in regulating dietary cholesterol absorption - The sitosterolemia locus is found at chromosome 2p21. J Clin Investig. 1998, 102: 1041-1044.","journal-title":"J Clin Investig"},{"key":"179_CR79","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11883-014-0424-2","volume":"16","author":"JC Escola-Gil","year":"2014","unstructured":"Escola-Gil JC, Quesada H, Julve J, Martin-Campos JM, Cedo L, Blanco-Vaca F: Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep. 2014, 16: 424-","journal-title":"Curr Atheroscler Rep"},{"key":"179_CR80","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI107640","volume":"53","author":"AK Bhattacharyya","year":"1974","unstructured":"Bhattacharyya AK, Connor WE: Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 1974, 53: 1033-1043.","journal-title":"J Clin Invest"},{"key":"179_CR81","unstructured":"Merkens LS, Myrie SB, Steiner RD, Mymin D: Sitosterolemia. In GeneReviews(R). Edited by Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K. Seattle (WA): 1993."},{"key":"179_CR82","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ajh.23619","volume":"89","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cao L, Su Y, Wang G, Wang R, Yu Z, Bai X, Ruan C: Specific macrothrombocytopenia\/hemolytic anemia associated with sitosterolemia. Am J Hematol. 2014, 89: 320-324.","journal-title":"Am J Hematol"},{"key":"179_CR83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","volume":"109","author":"G Salen","year":"2004","unstructured":"Salen G, von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, Musser B: Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation. 2004, 109: 966-971.","journal-title":"Circulation"},{"key":"179_CR84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5551\/jat.20040","volume":"21","author":"T Teramoto","year":"2014","unstructured":"Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Harada-Shiba M, Arai H, Bujo H, Nohara A, Ohta T, Oikawa S, Okada T, Wakatsuki A: Familial hypercholesterolemia. J Atheroscler Thromb. 2014, 21: 6-10.","journal-title":"J Atheroscler Thromb"},{"key":"179_CR85","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","volume":"111","author":"DJ Rader","year":"2003","unstructured":"Rader DJ, Cohen J, Hobbs HH: Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest. 2003, 111: 1795-1803.","journal-title":"J Clin Invest"},{"key":"179_CR86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0190-9622(88)70157-7","volume":"19","author":"PD Cruz Jr","year":"1988","unstructured":"Cruz PD, East C, Bergstresser PR: Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 1988, 19: 95-111.","journal-title":"J Am Acad Dermatol"},{"key":"179_CR87","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jacl.2011.03.451","volume":"5","author":"JG Robinson","year":"2011","unstructured":"Robinson JG, Goldberg AC: Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011, 5: S18-S29.","journal-title":"J Clin Lipidol"},{"key":"179_CR88","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-985073","volume":"27","author":"JE Heubi","year":"2007","unstructured":"Heubi JE, Setchell KD, Bove KE: Inborn errors of bile acid metabolism. Semin Liver Dis. 2007, 27: 282-294.","journal-title":"Semin Liver Dis"},{"key":"179_CR89","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI112915","volume":"79","author":"PT Clayton","year":"1987","unstructured":"Clayton PT, Leonard JV, Lawson AM, Setchell KD, Andersson S, Egestad B, Sjovall J: Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. J Clin Invest. 1987, 79: 1031-1038.","journal-title":"J Clin Invest"},{"key":"179_CR90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/gast.2003.50017","volume":"124","author":"KD Setchell","year":"2003","unstructured":"Setchell KD, Heubi JE, Bove KE, O\u2019Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH: Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology. 2003, 124: 217-232.","journal-title":"Gastroenterology"},{"key":"179_CR91","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neurol.2014.01.675","volume":"170","author":"C Lionnet","year":"2014","unstructured":"Lionnet C, Carra C, Ayrignac X, Levade T, Gayraud D, Castelnovo G, Besson G, Androdias G, Vukusic S, Confavreux C, Zaenker C, De Seze J, Collongues N, Blanc F, Tranchant C, Wallon D, Hannequin D, Gerdelat-Mas A, Brassat D, Clanet M, Zephir H, Outteryck O, Vermersch P, Labauge P: [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]. Rev Neurol (Paris). 2014, 170: 445-453.","journal-title":"Rev Neurol (Paris)"},{"key":"179_CR92","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.1840070210","volume":"7","author":"I Bjorkhem","year":"1987","unstructured":"Bjorkhem I, Skrede S, Buchmann MS, East C, Grundy S: Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid. Hepatology. 1987, 7: 266-271.","journal-title":"Hepatology"},{"key":"179_CR93","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1468-1331.2010.03002.x","volume":"17","author":"GN Gallus","year":"2010","unstructured":"Gallus GN, Dotti MT, Mignarri A, Rufa A, Da Pozzo P, Cardaioli E, Federico A: Four novel CYP27A1 mutations in seven Italian patients with CTX. Eur J Neurol. 2010, 17: 1259-1262.","journal-title":"Eur J Neurol"},{"key":"179_CR94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0026-0495(99)90040-9","volume":"48","author":"A Verrips","year":"1999","unstructured":"Verrips A, Wevers RA, Van Engelen BG, Keyser A, Wolthers BG, Barkhof F, Stalenhoef A, De Graaf R, Janssen-Zijlstra F, Van Spreeken A, Gabreels FJ: Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism. 1999, 48: 233-238.","journal-title":"Metabolism"},{"issue":"Suppl 2","key":"179_CR95","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1007\/s10545-008-0815-z","volume":"31","author":"G Pierre","year":"2008","unstructured":"Pierre G, Setchell K, Blyth J, Preece MA, Chakrapani A, McKiernan P: Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy. J Inherit Metab Dis. 2008, 31 (Suppl 2): S241-S245.","journal-title":"J Inherit Metab Dis"},{"key":"179_CR96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-8981(85)90182-2","volume":"152","author":"BJ Koopman","year":"1985","unstructured":"Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ: Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Clin Chim Acta. 1985, 152: 115-122.","journal-title":"Clin Chim Acta"},{"issue":"Suppl 1","key":"179_CR97","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.mpg.0000226386.79483.7b","volume":"43","author":"KDR Setchell","year":"2006","unstructured":"Setchell KDR, Heubi JE: Defects in bile acid biosynthesis\u2013diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2006, 43 (Suppl 1): S17-S22.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"179_CR98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0022-510X(94)90237-2","volume":"125","author":"M Kuriyama","year":"1994","unstructured":"Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M: Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use. J Neurol Sci. 1994, 125: 22-28.","journal-title":"J Neurol Sci"},{"key":"179_CR99","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1212\/WNL.44.11.2218","volume":"44","author":"A Federico","year":"1994","unstructured":"Federico A, Dotti MT: Treatment of cerebrotendinous xanthomatosis. Neurology. 1994, 44: 2218-","journal-title":"Neurology"},{"key":"179_CR100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-510X(93)90303-G","volume":"114","author":"Y Mimura","year":"1993","unstructured":"Mimura Y, Kuriyama M, Tokimura Y, Fujiyama J, Osame M, Takesako K, Tanaka N: Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis. J Neurol Sci. 1993, 114: 227-230.","journal-title":"J Neurol Sci"},{"key":"179_CR101","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mds.22979","volume":"25","author":"C-S Su","year":"2010","unstructured":"Su C-S, Chang W-N, Huang S-H, Lui C-C, Pan T-L, Lu C-H, Chuang Y-C, Huang C-R, Tsai N-W, Hsieh M-J, Chang C-C: Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord: Offic J Mov Disord Soc. 2010, 25: 452-458.","journal-title":"Mov Disord: Offic J Mov Disord Soc"},{"key":"179_CR102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.parkreldis.2013.04.003","volume":"19","author":"J Lagarde","year":"2013","unstructured":"Lagarde J, Sedel F, Degos B: Blepharospasm as a new feature of cerebrotendinous xanthomatosis. Parkinsonism Relat Disord. 2013, 19: 764-765.","journal-title":"Parkinsonism Relat Disord"},{"key":"179_CR103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/WNF.0b013e318288076a","volume":"36","author":"G Yahalom","year":"2013","unstructured":"Yahalom G, Tsabari R, Molshatzki N, Ephraty L, Cohen H, Hassin-Baer S: Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis. Clin Neuropharmacol. 2013, 36: 78-83.","journal-title":"Clin Neuropharmacol"},{"key":"179_CR104","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1074\/jbc.273.24.14805","volume":"273","author":"H Rosen","year":"1998","unstructured":"Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, Eggertsen G, Bjorkhem I, Leitersdorf E: Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem. 1998, 273: 14805-14812.","journal-title":"J Biol Chem"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0179-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0179-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:43:32Z","timestamp":1630550612000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0179-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]},"assertion":[{"value":"10 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"179"}}